NEVRO CORP. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2017-11-06: Form 8-K; Period of report 2017-11-06; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2017-08-07: Form 8-K; Period of report 2017-08-07; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2017-07-05: Form 8-K; Period of report 2017-07-03; Description 2.02 Results of Operations and Financial Condition; 8.01 Other Events; Details 2.02.
- 2017-05-31: Form 8-K; Period of report 2017-05-25; Description 5.07 Submission of Matters to a Vote of Security Holders; Details 5.07.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2017-11-06 | 8-K | 2017-11-06 | 2.02 Results of Operations and Financial Condition | 2.02 On November 6, 2017, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its financial results for the three and nine months ended September 30, 2017. | nvro-8k_20171106.htm |
| 2017-08-07 | 8-K | 2017-08-07 | 2.02 Results of Operations and Financial Condition | 2.02 On August 7, 2017, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its financial results for the three and six months ended June 30, 2017. | nvro-8k_20170807.htm |
| 2017-07-05 | 8-K | 2017-07-03 | 2.02 Results of Operations and Financial Condition; 8.01 Other Events | 2.02 On July 5, 2017, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its preliminary unaudited revenue for the three months ended June 30, 2017. 8.01 Effective as of July 3, 2017, Michael Enxing, Vice President of Sales, is no longer with the Company. | nvro-8k_20170703.htm |
| 2017-05-31 | 8-K | 2017-05-25 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 On May 25, 2017, Nevro Corp. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). | nvro-8k_20170525.htm |
| 2017-05-08 | 8-K | 2017-05-08 | 2.02 Results of Operations and Financial Condition | 2.02 On May 8, 2017, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its financial results for the three months ended March 31, 2017. | nvro-8k_20170508.htm |
| 2017-02-23 | 8-K | 2017-02-23 | 2.02 Results of Operations and Financial Condition | 2.02 On February 23, 2017, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its financial results for the three months and full year ended December 31, 2016. | nvro-8k_20170223.htm |
| 2017-01-04 | 8-K | 2016-12-31 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On December 31, 2016, Michael DeMane announced his intention to transition from Executive Chairman of Nevro Corp. (“Nevro” or the “Company”) to Chairman of the Board of Directors of Nevro effective as of January 1, 2017 in accordance with the terms of his amended employment agreement and cease his employment as an executive officer of the Company. | nvro-8k_20161231.htm |